Sumitomo Dainippon Pharma Co's total assets for Q3 2024 were ¥852.12B, an increase of 6.55% from the previous quarter. JP:4506 total liabilities were ¥686.00B for the fiscal quarter, a 0.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.